Please check your internet connection and try again.
# Miconazole Vaginal Pessary
## Overview
Miconazole vaginal pessaries are a topical antifungal agent used to treat vulvovaginal candidiasis (yeast infections). They work by disrupting the fungal cell membrane.
## Primary Indications
* Vulvovaginal candidiasis (yeast infections) caused by *Candida albicans* and other susceptible *Candida* species.
## Adult Dosing
Commonly available as 100 mg, 200 mg, or 1200 mg pessaries.
* **100 mg pessary:** Insert one pessary vaginally at bedtime for 7 consecutive nights.
* **200 mg pessary:** Insert one pessary vaginally at bedtime for 3 consecutive nights.
* **1200 mg pessary:** Insert one pessary vaginally as a single dose.
Duration of therapy depends on the strength of the pessary used.
## Pediatric Dosing
Data for use in pediatric patients is limited. Consult product labeling or specialist guidance. Generally, lower strengths and shorter durations may be considered for adolescents, but caution is advised. Not typically recommended for prepubertal children.
## Dose Adjustments
No dose adjustment is typically required based on renal or hepatic impairment for vaginal administration due to minimal systemic absorption.
## Contraindications
* Hypersensitivity to miconazole or any component of the formulation.
## Adverse Effects
* **Common:** Vaginal burning, itching, irritation, cramping.
* **Less Common:** Rash, hives.
## Key Drug Interactions
* **Warfarin:** Miconazole, particularly oral formulations, can significantly increase warfarin levels. While systemic absorption from vaginal pessaries is minimal, caution and monitoring of INR may be considered if used concurrently with warfarin, especially in cases of extensive use, damaged vaginal mucosa, or prolonged therapy.
* **CYP3A4 Inhibitors:** Miconazole is a CYP3A4 inhibitor. Concurrent use with other CYP3A4 substrates may lead to increased concentrations of those drugs. Systemic absorption is generally low with vaginal use, making this interaction less likely but not impossible.
## Monitoring
* Monitor for symptom resolution (e.g., reduction in itching, burning, discharge).
* Monitor for signs of local irritation or allergic reaction.
## Clinical Pearls
* Advise patients to complete the full course of therapy, even if symptoms improve earlier.
* Avoid sexual intercourse during treatment to prevent potential irritation and transmission to a partner.
* Consider the use of miconazole cream for external vulvar itching if needed.
* Pregnancy: While generally considered low risk, consult healthcare provider before use in pregnant individuals, especially during the first trimester.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the official prescribing information and relevant clinical guidelines for the most up-to-date and comprehensive drug information.*
